Antonio García Merino J
Unidad de Neuroinmunología, Servicio de Neurología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
Med Clin (Barc). 2014 Dec;143 Suppl 3:19-22. doi: 10.1016/S0025-7753(15)30005-1.
Since the introduction of interferon beta 1 b for the treatment of multiple sclerosis, there has been a progressive increase in the number of drugs available for this disease. Currently, 11 drugs have been approved in Spain, and their indications depend on specific clinical characteristics. The present article reviews these indications and also discusses other medications without official approval that have also been used in multiple sclerosis.
自从引入β-1b干扰素用于治疗多发性硬化症以来，针对该疾病的可用药物数量一直在逐步增加。目前，西班牙已批准了11种药物，其适应症取决于特定的临床特征。本文回顾了这些适应症，并讨论了其他未获官方批准但也已用于治疗多发性硬化症的药物。
